Wednesday , June 20 2018
Home / KEEP BUT DO NOT DISPLAY / Alerts / Afrezza Inhaled Insulin Approved by FDA Panel for Type 1 and Type 2 Diabetes

Afrezza Inhaled Insulin Approved by FDA Panel for Type 1 and Type 2 Diabetes

Apr 3, 2014
 

Afrezza Inhaled Insulin Approved by FDA Panel for Type 1 and Type 2 Diabetes

See our feature article, FDA Panel Approves Inhaled Insulin, Again.